MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

PURPOSE: To develop a risk score for patients with advanced systemic mastocytosis (AdvSM) that integrates clinical and mutation characteristics. PATIENTS AND METHODS: The study included 383 patients with AdvSM from the German Registry on Disorders of Eosinophils and Mast Cells (training set; n = 231...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawhar, Mohamad, Schwaab, Juliana, Álvarez-Twose, Iván, Shoumariyeh, Khalid, Naumann, Nicole, Lübke, Johannes, Perkins, Cecelia, Muñoz-González, Javier I., Meggendorfer, Manja, Kennedy, Vanessa, Metzgeroth, Georgia, Fabarius, Alice, Pfeifer, Dietmar, Sotlar, Karl, Horny, Hans-Peter, von Bubnoff, Nikolas, Haferlach, Torsten, Cross, Nicholas C.P., Hofmann, Wolf-Karsten, Sperr, Wolfgang R., García-Montero, Andrés C., Valent, Peter, Gotlib, Jason, Orfao, Alberto, Reiter, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823885/
https://www.ncbi.nlm.nih.gov/pubmed/31509472
http://dx.doi.org/10.1200/JCO.19.00640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823885/
https://www.ncbi.nlm.nih.gov/pubmed/31509472
http://dx.doi.org/10.1200/JCO.19.00640

Ejemplares similares